Wedbush Securities’s Theriva Biologics TOVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-526
Closed -$67K 1006
2019
Q4
$67K Buy
526
+100
+23% +$10.6K 0.01% 950
2019
Q3
$48K Buy
426
+34
+9% +$4.11K ﹤0.01% 942
2019
Q2
$54K Buy
+392
New +$56.4K 0.01% 944
2018
Q3
Sell
-15
Closed -$32K 943
2018
Q2
$32K Hold
15
﹤0.01% 852
2018
Q1
$42K Buy
15
+6
+67% +$22.8K 0.01% 789
2017
Q4
$39K Buy
9
+3
+50% +$18.7K ﹤0.01% 827
2017
Q3
$46K Sell
6
-1
-14% -$5.78K 0.01% 808
2017
Q2
$35K Buy
7
+1
+17% +$4.98K ﹤0.01% 812
2017
Q1
$31K Buy
6
+5
+500% +$34.9K ﹤0.01% 820
2016
Q4
$8K Sell
1
-2
-67% -$20.5K ﹤0.01% 814
2016
Q3
$38K Hold
3
0.01% 801
2016
Q2
$40K Hold
3
0.01% 742
2016
Q1
$52K Hold
3
0.01% 698
2015
Q4
$50K Hold
3
0.01% 682
2015
Q3
$50K Buy
3
+2
+200% +$49.2K 0.01% 664
2015
Q2
$34K Hold
1
0.01% 701
2015
Q1
$26K Hold
1
﹤0.01% 717
2014
Q4
$18K Buy
+1
New +$13.4K ﹤0.01% 701

Other funds holding TOVX